Omics technologies provide valuable tools to study aging at the molecular level. CD BioSciences can provide genomic, epigenomic, transcriptomic, proteomic, and metabolomic approaches that allow the integration of different types of aging data and drive further development of research in this field.
The rapid development of omics technologies has led to the application of several systematic approaches to aging research. We offer a variety of omics methods for use in the field of aging research to expand the overall understanding of the aging process, in addition to helping to identify biomarkers of aging.
CD BioSciences offers a wide range of services to support scientific advancements in this field of multi-omics analysis for aging biology. Whether you require genomics, epigenetics, transcriptomics, proteomics, or metabolomics analysis, we provide customized solutions tailored to meet your specific research needs.
CD BioSciences provides genomic analysis to understand the genetic basis of aging. By utilizing state-of-the-art sequencing technologies, such as mitochondrial genome sequencing, whole-genome sequencing, and exome sequencing. We can identify genetic variations and mutations associated with aging.
We employ epigenetic modification analysis services to know changes in gene expression that occur without altering the underlying DNA sequence. It plays a crucial role in aging, as it controls gene activity and influences various biological processes. We offer cutting-edge epigenetic services that enable researchers to investigate DNA methylation, histone modifications, and non-coding RNA expression patterns associated with aging.
We offer transcriptomic profiling services, which is a major determinant of age-related phenotypic diversity. Therefore, our systematic analysis of the aging transcriptome can help our clients discover and enrich the mechanisms of molecular changes in aging. We also can capture certain specific changes in the global transcriptome of aging and differential gene expression for researchers.
Our proteomics research has potential in aging exploration, as proteins may be the most promising biomarker candidates in aging. Age proteomes are highly tissue-specific, and they can be used as tools for exploratory analysis and problem-solving in aging research. We use LC-MS/MS technology to provide proteome analysis of numerous biological samples to obtain a comprehensive proteomic data set.
CD BioSciences recognizes the importance of studying immunological changes in the aging population and offers advanced immunomic services. We provide immunomic services for aging research, such as immune profiling, biomarker discovery, immunogenomic, immunoproteomic, and the development of immunomic aging clocks, for investigating the complex relationship between the immune system and aging.
We offer metabolomic analyses whose measured metabolites are the end products of gene and protein regulation and can directly characterize the physiological pathways and states of the aging process. Our metabolomics services have the potential to provide clients with innovative insights into the biological processes and molecular mechanisms of aging.
We help our clients explore the diversity of cells within aging tissues using the power of single-cell technologies that can capture cellular heterogeneity. We offer cutting-edge single-cell holography services for aging research, including single-cell genomics, transcriptomics, epigenomics, proteomics, and metabolomics services.
We utilize cutting-edge spatial omics services that enable our clients to investigate the spatial distribution of molecules within tissues during the aging process.
We provide multi-omics analysis of aging, integrating new methods to improve the measurement of biological aging and reveal aging mechanisms and their effects at several molecular levels.
Multiple omics approaches are important research tools in aging research, and the integration of these findings may ultimately help us explore new research directions. We offer a variety of omics research services for aging research to help our clients with technical challenges and advance their research. CD BioSciences invites you to partner with us, please contact us or make an online inquiry.
Reference
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.